Staq Pharma
STAQ Pharma: Ensuring safety and quality in compounded medications through onsite production and proactive inventory.
Founded
2018STAQ Pharma: Ensuring safety and quality in compounded medications through onsite production and proactive inventory.
Founded in 2018 and headquartered in Denver, Colorado, STAQ Pharma is dedicated to enhancing the safety, transparency, availability, and quality of compounded medications. The company specializes in the onsite production of non-sterile to sterile solutions and sterile-to-sterile repackaging. Their inventory systems are designed to forecast needs and proactively supply partners with critical products. STAQ Pharma operates a state-of-the-art 503B pharmaceutical outsourcing facility that adheres to cGMP compliance, focusing on sterile, injectable medical compounding.
Notable for its advanced capabilities, STAQ Pharma employs robotic automation to ensure sterility and precision, offering pre-filled pediatric and adult concentrations. Each batch comes with a Certificate of Analysis (COA), underscoring their commitment to quality. The facility can produce up to thousands of syringes per day, positioning STAQ Pharma as a leader in the compounding pharmacy market. Their impact is significant in providing reliable, high-quality compounded medications to healthcare providers, thereby improving patient safety and care standards.
Companies similar to Staq Pharma include QuVa Pharma, RXQ Compounding, Sterrx and Amphastar Pharmaceuticals.
Staq Pharma was founded in 2018.
Staq Pharma's headquarters is located in Denver, CO, US.
Staq Pharma's most recent funding round was for $10.1M (USD) in April 2023.
As of Apr 28, 2023, Staq Pharma has disclosed funding of $19.1M (USD). Undisclosed round amounts are excluded.
Staq Pharma has 175 employees as of Feb 5, 2024.
amphastar.com
